img

Global Oral Peptide Drug Market Research Report 2024

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Oral Peptide Drug Market Research Report 2024

The drugs give through oral.
According to Mr Accuracy reports new survey, global Oral Peptide Drug market is projected to reach US$ 7980.1 million in 2029, increasing from US$ 2000 million in 2022, with the CAGR of 15.0% during the period of 2024 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Oral Peptide Drug market research.
The Peptide Drug market is driven by the increasing recognition of peptides as a versatile and promising class of therapeutics. Peptides offer the potential to target specific biological pathways and cellular functions with high specificity, making them valuable candidates for treating a wide range of diseases, including cancer, metabolic disorders, and cardiovascular conditions. The growing understanding of peptide structure-activity relationships, coupled with advancements in peptide synthesis and modification techniques, contribute to the development of more stable and bioavailable peptide drugs, fostering market growth. Moreover, the rise in personalized medicine approaches and the need for more targeted therapies align with the development of peptide-based treatments that can be tailored to individual patient profiles. However, the market also faces challenges, including optimizing peptide delivery systems, enhancing bioavailability, and addressing potential immunogenicity and stability issues. Additionally, the complexity of peptide synthesis, the need for stringent regulatory approvals, and the competition from other therapeutic modalities pose obstacles for manufacturers and researchers. To succeed, stakeholders must focus on innovative peptide design, efficient synthesis methods, and comprehensive pre-clinical and clinical studies to demonstrate the safety and efficacy of peptide drugs. Addressing challenges while harnessing the therapeutic potential of peptides will be essential for driving the growth and adoption of peptide-based treatments in various medical applications.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Oral Peptide Drug market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Allergan
Novo Nordisk
Synergy Pharmaceuticals （Salix）
Novartis
Chiasma
Segment by Type
Linaclotide
Insulin
Plecanatide
Cyclosporine
Octreotide

Segment by Application


Hospital
Retail Pharmacy
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Oral Peptide Drug report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Oral Peptide Drug Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Linaclotide
1.2.3 Insulin
1.2.4 Plecanatide
1.2.5 Cyclosporine
1.2.6 Octreotide
1.3 Market by Application
1.3.1 Global Oral Peptide Drug Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Retail Pharmacy
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Oral Peptide Drug Market Perspective (2018-2029)
2.2 Oral Peptide Drug Growth Trends by Region
2.2.1 Global Oral Peptide Drug Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Oral Peptide Drug Historic Market Size by Region (2018-2024)
2.2.3 Oral Peptide Drug Forecasted Market Size by Region (2024-2029)
2.3 Oral Peptide Drug Market Dynamics
2.3.1 Oral Peptide Drug Industry Trends
2.3.2 Oral Peptide Drug Market Drivers
2.3.3 Oral Peptide Drug Market Challenges
2.3.4 Oral Peptide Drug Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Oral Peptide Drug Players by Revenue
3.1.1 Global Top Oral Peptide Drug Players by Revenue (2018-2024)
3.1.2 Global Oral Peptide Drug Revenue Market Share by Players (2018-2024)
3.2 Global Oral Peptide Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Oral Peptide Drug Revenue
3.4 Global Oral Peptide Drug Market Concentration Ratio
3.4.1 Global Oral Peptide Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Oral Peptide Drug Revenue in 2022
3.5 Oral Peptide Drug Key Players Head office and Area Served
3.6 Key Players Oral Peptide Drug Product Solution and Service
3.7 Date of Enter into Oral Peptide Drug Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Oral Peptide Drug Breakdown Data by Type
4.1 Global Oral Peptide Drug Historic Market Size by Type (2018-2024)
4.2 Global Oral Peptide Drug Forecasted Market Size by Type (2024-2029)
5 Oral Peptide Drug Breakdown Data by Application
5.1 Global Oral Peptide Drug Historic Market Size by Application (2018-2024)
5.2 Global Oral Peptide Drug Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Oral Peptide Drug Market Size (2018-2029)
6.2 North America Oral Peptide Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Oral Peptide Drug Market Size by Country (2018-2024)
6.4 North America Oral Peptide Drug Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Oral Peptide Drug Market Size (2018-2029)
7.2 Europe Oral Peptide Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Oral Peptide Drug Market Size by Country (2018-2024)
7.4 Europe Oral Peptide Drug Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Oral Peptide Drug Market Size (2018-2029)
8.2 Asia-Pacific Oral Peptide Drug Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Oral Peptide Drug Market Size by Region (2018-2024)
8.4 Asia-Pacific Oral Peptide Drug Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Oral Peptide Drug Market Size (2018-2029)
9.2 Latin America Oral Peptide Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Oral Peptide Drug Market Size by Country (2018-2024)
9.4 Latin America Oral Peptide Drug Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Oral Peptide Drug Market Size (2018-2029)
10.2 Middle East & Africa Oral Peptide Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Oral Peptide Drug Market Size by Country (2018-2024)
10.4 Middle East & Africa Oral Peptide Drug Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Allergan
11.1.1 Allergan Company Detail
11.1.2 Allergan Business Overview
11.1.3 Allergan Oral Peptide Drug Introduction
11.1.4 Allergan Revenue in Oral Peptide Drug Business (2018-2024)
11.1.5 Allergan Recent Development
11.2 Novo Nordisk
11.2.1 Novo Nordisk Company Detail
11.2.2 Novo Nordisk Business Overview
11.2.3 Novo Nordisk Oral Peptide Drug Introduction
11.2.4 Novo Nordisk Revenue in Oral Peptide Drug Business (2018-2024)
11.2.5 Novo Nordisk Recent Development
11.3 Synergy Pharmaceuticals （Salix）
11.3.1 Synergy Pharmaceuticals （Salix） Company Detail
11.3.2 Synergy Pharmaceuticals （Salix） Business Overview
11.3.3 Synergy Pharmaceuticals （Salix） Oral Peptide Drug Introduction
11.3.4 Synergy Pharmaceuticals （Salix） Revenue in Oral Peptide Drug Business (2018-2024)
11.3.5 Synergy Pharmaceuticals （Salix） Recent Development
11.4 Novartis
11.4.1 Novartis Company Detail
11.4.2 Novartis Business Overview
11.4.3 Novartis Oral Peptide Drug Introduction
11.4.4 Novartis Revenue in Oral Peptide Drug Business (2018-2024)
11.4.5 Novartis Recent Development
11.5 Chiasma
11.5.1 Chiasma Company Detail
11.5.2 Chiasma Business Overview
11.5.3 Chiasma Oral Peptide Drug Introduction
11.5.4 Chiasma Revenue in Oral Peptide Drug Business (2018-2024)
11.5.5 Chiasma Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Oral Peptide Drug Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Linaclotide
Table 3. Key Players of Insulin
Table 4. Key Players of Plecanatide
Table 5. Key Players of Cyclosporine
Table 6. Key Players of Octreotide
Table 7. Global Oral Peptide Drug Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 8. Global Oral Peptide Drug Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 9. Global Oral Peptide Drug Market Size by Region (2018-2024) & (US$ Million)
Table 10. Global Oral Peptide Drug Market Share by Region (2018-2024)
Table 11. Global Oral Peptide Drug Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 12. Global Oral Peptide Drug Market Share by Region (2024-2029)
Table 13. Oral Peptide Drug Market Trends
Table 14. Oral Peptide Drug Market Drivers
Table 15. Oral Peptide Drug Market Challenges
Table 16. Oral Peptide Drug Market Restraints
Table 17. Global Oral Peptide Drug Revenue by Players (2018-2024) & (US$ Million)
Table 18. Global Oral Peptide Drug Market Share by Players (2018-2024)
Table 19. Global Top Oral Peptide Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oral Peptide Drug as of 2022)
Table 20. Ranking of Global Top Oral Peptide Drug Companies by Revenue (US$ Million) in 2022
Table 21. Global 5 Largest Players Market Share by Oral Peptide Drug Revenue (CR5 and HHI) & (2018-2024)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Oral Peptide Drug Product Solution and Service
Table 24. Date of Enter into Oral Peptide Drug Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Oral Peptide Drug Market Size by Type (2018-2024) & (US$ Million)
Table 27. Global Oral Peptide Drug Revenue Market Share by Type (2018-2024)
Table 28. Global Oral Peptide Drug Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 29. Global Oral Peptide Drug Revenue Market Share by Type (2024-2029)
Table 30. Global Oral Peptide Drug Market Size by Application (2018-2024) & (US$ Million)
Table 31. Global Oral Peptide Drug Revenue Market Share by Application (2018-2024)
Table 32. Global Oral Peptide Drug Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 33. Global Oral Peptide Drug Revenue Market Share by Application (2024-2029)
Table 34. North America Oral Peptide Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 35. North America Oral Peptide Drug Market Size by Country (2018-2024) & (US$ Million)
Table 36. North America Oral Peptide Drug Market Size by Country (2024-2029) & (US$ Million)
Table 37. Europe Oral Peptide Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 38. Europe Oral Peptide Drug Market Size by Country (2018-2024) & (US$ Million)
Table 39. Europe Oral Peptide Drug Market Size by Country (2024-2029) & (US$ Million)
Table 40. Asia-Pacific Oral Peptide Drug Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 41. Asia-Pacific Oral Peptide Drug Market Size by Region (2018-2024) & (US$ Million)
Table 42. Asia-Pacific Oral Peptide Drug Market Size by Region (2024-2029) & (US$ Million)
Table 43. Latin America Oral Peptide Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 44. Latin America Oral Peptide Drug Market Size by Country (2018-2024) & (US$ Million)
Table 45. Latin America Oral Peptide Drug Market Size by Country (2024-2029) & (US$ Million)
Table 46. Middle East & Africa Oral Peptide Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 47. Middle East & Africa Oral Peptide Drug Market Size by Country (2018-2024) & (US$ Million)
Table 48. Middle East & Africa Oral Peptide Drug Market Size by Country (2024-2029) & (US$ Million)
Table 49. Allergan Company Detail
Table 50. Allergan Business Overview
Table 51. Allergan Oral Peptide Drug Product
Table 52. Allergan Revenue in Oral Peptide Drug Business (2018-2024) & (US$ Million)
Table 53. Allergan Recent Development
Table 54. Novo Nordisk Company Detail
Table 55. Novo Nordisk Business Overview
Table 56. Novo Nordisk Oral Peptide Drug Product
Table 57. Novo Nordisk Revenue in Oral Peptide Drug Business (2018-2024) & (US$ Million)
Table 58. Novo Nordisk Recent Development
Table 59. Synergy Pharmaceuticals （Salix） Company Detail
Table 60. Synergy Pharmaceuticals （Salix） Business Overview
Table 61. Synergy Pharmaceuticals （Salix） Oral Peptide Drug Product
Table 62. Synergy Pharmaceuticals （Salix） Revenue in Oral Peptide Drug Business (2018-2024) & (US$ Million)
Table 63. Synergy Pharmaceuticals （Salix） Recent Development
Table 64. Novartis Company Detail
Table 65. Novartis Business Overview
Table 66. Novartis Oral Peptide Drug Product
Table 67. Novartis Revenue in Oral Peptide Drug Business (2018-2024) & (US$ Million)
Table 68. Novartis Recent Development
Table 69. Chiasma Company Detail
Table 70. Chiasma Business Overview
Table 71. Chiasma Oral Peptide Drug Product
Table 72. Chiasma Revenue in Oral Peptide Drug Business (2018-2024) & (US$ Million)
Table 73. Chiasma Recent Development
Table 74. Research Programs/Design for This Report
Table 75. Key Data Information from Secondary Sources
Table 76. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Oral Peptide Drug Market Size Comparison by Type (2024-2034) & (US$ Million)
Figure 2. Global Oral Peptide Drug Market Share by Type: 2022 VS 2029
Figure 3. Linaclotide Features
Figure 4. Insulin Features
Figure 5. Plecanatide Features
Figure 6. Cyclosporine Features
Figure 7. Octreotide Features
Figure 8. Global Oral Peptide Drug Market Size Comparison by Application (2024-2034) & (US$ Million)
Figure 9. Global Oral Peptide Drug Market Share by Application: 2022 VS 2029
Figure 10. Hospital Case Studies
Figure 11. Retail Pharmacy Case Studies
Figure 12. Oral Peptide Drug Report Years Considered
Figure 13. Global Oral Peptide Drug Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 14. Global Oral Peptide Drug Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 15. Global Oral Peptide Drug Market Share by Region: 2022 VS 2029
Figure 16. Global Oral Peptide Drug Market Share by Players in 2022
Figure 17. Global Top Oral Peptide Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oral Peptide Drug as of 2022)
Figure 18. The Top 10 and 5 Players Market Share by Oral Peptide Drug Revenue in 2022
Figure 19. North America Oral Peptide Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 20. North America Oral Peptide Drug Market Share by Country (2018-2029)
Figure 21. United States Oral Peptide Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Canada Oral Peptide Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Europe Oral Peptide Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Europe Oral Peptide Drug Market Share by Country (2018-2029)
Figure 25. Germany Oral Peptide Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. France Oral Peptide Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. U.K. Oral Peptide Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Italy Oral Peptide Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Russia Oral Peptide Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Nordic Countries Oral Peptide Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Asia-Pacific Oral Peptide Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Asia-Pacific Oral Peptide Drug Market Share by Region (2018-2029)
Figure 33. China Oral Peptide Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Japan Oral Peptide Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. South Korea Oral Peptide Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Southeast Asia Oral Peptide Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. India Oral Peptide Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Australia Oral Peptide Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Latin America Oral Peptide Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Latin America Oral Peptide Drug Market Share by Country (2018-2029)
Figure 41. Mexico Oral Peptide Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Brazil Oral Peptide Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Middle East & Africa Oral Peptide Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Middle East & Africa Oral Peptide Drug Market Share by Country (2018-2029)
Figure 45. Turkey Oral Peptide Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Saudi Arabia Oral Peptide Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Allergan Revenue Growth Rate in Oral Peptide Drug Business (2018-2024)
Figure 48. Novo Nordisk Revenue Growth Rate in Oral Peptide Drug Business (2018-2024)
Figure 49. Synergy Pharmaceuticals （Salix） Revenue Growth Rate in Oral Peptide Drug Business (2018-2024)
Figure 50. Novartis Revenue Growth Rate in Oral Peptide Drug Business (2018-2024)
Figure 51. Chiasma Revenue Growth Rate in Oral Peptide Drug Business (2018-2024)
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries